These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22301054)

  • 21. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital.
    Lertkhachonsuk R; Manchana T; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Sirisabya N; Khemapech N; Tresukosol D
    J Med Assoc Thai; 2006 Feb; 89(2):138-44. PubMed ID: 16578998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of ovarian germ cell tumours.
    Newlands ES
    Forum (Genova); 2000; 10(4):368-80. PubMed ID: 11535986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conservative surgery in patients with malignant ovarian germ cell tumours.
    Al-Sayed MM; El-Sayed AA; El-Barbary TM; Hamad O
    J Egypt Soc Parasitol; 2011 Dec; 41(3):737-44. PubMed ID: 22435165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of ovarian germ cell tumors.
    Gershenson DM
    J Clin Oncol; 2007 Jul; 25(20):2938-43. PubMed ID: 17617525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study.
    Sigismondi C; Scollo P; Ferrandina G; Candiani M; Angioli R; Viganò R; Scarfone G; Mangili G
    Int J Gynecol Cancer; 2015 Feb; 25(2):203-7. PubMed ID: 25569816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive function after treatment of ovarian germ cell malignancy.
    Anita AN; Rushdan MN
    Med J Malaysia; 2012 Feb; 67(1):71-6. PubMed ID: 22582552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
    Schröder W
    Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
    Weinberg LE; Lurain JR; Singh DK; Schink JC
    Gynecol Oncol; 2011 May; 121(2):285-9. PubMed ID: 21256579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual function.
    Campos SM; Berlin S; Matulonis UA; Muto MG; Pereira L; Mosquera MM; Horowitz N
    J Psychosoc Oncol; 2012; 30(4):387-401. PubMed ID: 22747104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
    Zhang M; Jiang W; Li G; Xu C
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of germ cell tumors of the ovary.
    Williams SD
    Semin Oncol; 1991 Jun; 18(3):292-6. PubMed ID: 1645889
    [No Abstract]   [Full Text] [Related]  

  • 36. Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors.
    Zanagnolo V; Sartori E; Trussardi E; Pasinetti B; Maggino T
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):235-43. PubMed ID: 15921842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conservative surgery for borderline ovarian tumors--emphasis on fertility preservation. A review.
    Koutlaki N; Dimitraki M; Zervoudis S; Sofiadou V; Grapsas X; Psillaki A; Nikas I; Galazios G; Liberis V; Voiculescu S; Burcoş T
    Chirurgia (Bucur); 2011; 106(6):715-22. PubMed ID: 22308907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical presentation and outcome of pediatric ovarian germ cell tumor: a study of 40 patients.
    Biswajit D; Patil CN; Sagar TG
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):e54-6. PubMed ID: 20168245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A successful IVF-pregnancy in a patient who underwent conservative surgery followed by a regimen of cisplatin, vinblastine and peplomycin to treat an advanced ovarian mixed germ cell tumour: a case report.
    Kitajima Y; Endo T; Hayashi T; Ishioka S; Baba T; Honnma H; Saito T
    Hum Reprod; 2007 Mar; 22(3):850-2. PubMed ID: 17067995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of malignant ovarian germ cell tumors.
    Parkinson CA; Hatcher HM; Ajithkumar TV
    Obstet Gynecol Surv; 2011 Aug; 66(8):507-14. PubMed ID: 22018453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.